Cargando…
Identification of Cell Type-Specific Differences in Erythropoietin Receptor Signaling in Primary Erythroid and Lung Cancer Cells
Lung cancer, with its most prevalent form non-small-cell lung carcinoma (NSCLC), is one of the leading causes of cancer-related deaths worldwide, and is commonly treated with chemotherapeutic drugs such as cisplatin. Lung cancer patients frequently suffer from chemotherapy-induced anemia, which can...
Autores principales: | Merkle, Ruth, Steiert, Bernhard, Salopiata, Florian, Depner, Sofia, Raue, Andreas, Iwamoto, Nao, Schelker, Max, Hass, Helge, Wäsch, Marvin, Böhm, Martin E., Mücke, Oliver, Lipka, Daniel B., Plass, Christoph, Lehmann, Wolf D., Kreutz, Clemens, Timmer, Jens, Schilling, Marcel, Klingmüller, Ursula |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975441/ https://www.ncbi.nlm.nih.gov/pubmed/27494133 http://dx.doi.org/10.1371/journal.pcbi.1005049 |
Ejemplares similares
-
Erythropoietin Improves the Accumulation and Therapeutic Effects of Carboplatin by Enhancing Tumor Vascularization and Perfusion
por: Doleschel, Dennis, et al.
Publicado: (2015) -
Correction: Lessons Learned from Quantitative Dynamical Modeling in Systems Biology
por: Raue, Andreas, et al.
Publicado: (2013) -
Comprehensive estimation of input signals and dynamics in biochemical reaction networks
por: Schelker, M., et al.
Publicado: (2012) -
Experimental Design for Parameter Estimation of Gene Regulatory Networks
por: Steiert, Bernhard, et al.
Publicado: (2012) -
Division of labor by dual feedback regulators controls JAK2/STAT5 signaling over broad ligand range
por: Bachmann, Julie, et al.
Publicado: (2011)